Literature DB >> 2562188

The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.

J Rappaport1, S J Lee, K Khalili, F Wong-Staal.   

Abstract

The Tat protein encoded by the human immunodeficiency virus (HIV) is an efficient activator of HIV gene expression. Many eukaryotic transcriptional activators contain a nucleic acid binding domain and a separate activating domain. These activating regions are acidic and often amphipathic. The amino terminus of the HIV-1 Tat protein is acidic with a periodicity of acidic, polar, and hydrophobic residues consistent with that of an amphipathic alpha helix. This region appears to be important for Tat function. We have analyzed the functional significance of acidic residues within the amino-terminal region of Tat by means of site-directed mutagenesis and by testing the capacity of mutant proteins to trans-activate the viral long terminal repeat (LTR) Conservative changes (acidic to acidic) were well tolerated, whereas acidic to neutral and acidic to basic changes markedly reduced Tat activity. The relative importance of each of the three acidic residues correlated with proximity to the amino terminus. Substitution of the entire domain with heterologous sequences that might form an acidic, amphipathic alpha helix partially restored activity when compared with an amino-terminal truncation mutant. In contrast to the observed importance of acidic residues, hydroxylated residues between amino acids 40 and 47 were dispensable for Tat function. These data suggest that the acidity of the amino terminal region is important for Tat function and that Tat-mediated trans-activation may be similar to that of other known activator proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562188

Source DB:  PubMed          Journal:  New Biol        ISSN: 1043-4674


  34 in total

1.  Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins.

Authors:  A P Rice; F Carlotti
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.

Authors:  M G Cordingley; R L LaFemina; P L Callahan; J H Condra; V V Sardana; D J Graham; T M Nguyen; K LeGrow; L Gotlib; A J Schlabach
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1.

Authors:  D A Brake; J Goudsmit; W J Krone; P Schammel; N Appleby; R H Meloen; C Debouck
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Transactivation of heterologous promoters by HIV-1 tat.

Authors:  P Han; R Brown; J Barsoum
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

5.  Mutational analysis of the equine infectious anemia virus Tat-responsive element.

Authors:  M Carvalho; D Derse
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 6.  Tat and Rev: positive modulators of human immunodeficiency virus gene expression.

Authors:  C A Rosen
Journal:  Gene Expr       Date:  1991-05

7.  A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.

Authors:  D M Benko; S Schwartz; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.

Authors:  M J Orsini; C M Debouck
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  The activation region of the Tat protein of human immunodeficiency virus type-1 functions in yeast.

Authors:  T Subramanian; C D'Sa-Eipper; B Elangovan; G Chinnadurai
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

10.  Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.

Authors:  M Chowdhury; J P Taylor; C F Chang; J Rappaport; K Khalili
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.